Attention Medtronic’s Defibrillator patients.

Certain Medtronic defibrillator leads with Sprint Fidelis leads are being recalled.  Call the law office of Dr. Brad Bradshaw, a physician, surgeon and lawyer, if you are affected by this recall.  Call our main office toll free at 888-775-0000 or visit our “contact us” page for the closest location to you.  Our office is willing to work with and refer cases to other attorneys as needed, and remember, the choice of lawyer is an important decision and should not be based solely upon advertisements

Below are some documents relating to this recall:

U.S. Government

• Congressional Committee on Oversight and Government Reform: Chairman Waxman's letter to FDA requesting information about the Agency’s approval of Medtronic’s Sprint Fidelis leads
• Senate Finance Committee: Senator Grassley asks for more information about heart defibrillator leads
• Letter to FDA Commissioner Andrew von Eschenbach
• Letter to Medtronic President and CEO Bill Hawkins

Food & Drug Administration (FDA)

• FDA Medwatch - Information for the Medtronic Recall
• FDA Recall Notice
• FDA Statement on Medtronic’s Voluntary Market Suspension of Their Sprint Fidelis Defibrillator Leads
• Medtronic Recalls Sprint Fidelis Cardiac Leads - Questions and Answers for Consumers

Medtronic Inc.

• Oct 14, 2007 Press Release
• Medtronic letter to patient
• Medtronic letter to physician

Other Links

• Letter from Dr. Sidney Wolfe of Public Citizen to FDA
• Abstract: Defibrillator Leads - Is Smaller Necessarily Better? - Study by Cornell University Medical Center physicians and researchers finding need to replace Medtronic Sprint Fidelis lead in 4% of patients